Elizabeth I. Buchbinder

An immunogenic personal neoantigen vaccine for patients with melanoma

Patrick A. Ott, Zhuting Hu, Derin B. Keskin et al. · Nature · 2017 · 2.8K citations · Full text

Vaccination, Tumor Immunology, Melanoma +5

A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

Livnat Jerby‐Arnon, Parin Shah, Michael S. Cuoco et al. · Cell · 2018 · 1.4K citations · Full text

Cancer Immunosurveillance, Medicine, Immunology +7

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

Sapna P. Patel, Megan Othus, Yuanbin Chen et al. · New England Journal of Medicine · 2023 · 741 citations · Full text

Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders

Douglas B. Johnson, Ryan J. Sullivan, Patrick A. Ott et al. · JAMA Oncology · 2015 · 653 citations

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study

Jeffrey S. Weber, Matteo S. Carlino, Adnan Khattak et al. · The Lancet · 2024 · 598 citations

Medicine, Melanoma, Immunology +7